Yahoo Finance

Myriad Genetics Expands Access to At-Home Early Fetal Sex DNA Test with Retail Launch

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Nasdaq

Myriad Genetics expands access to at-home early fetal sex DNA test

Myriad Genetics (MYGN) continues to empower parents with increased access to prenatal testing. SneakPeek is now available over the counter in more than 8,800 retail locations nationwide. The product ...
Medindia

Role of Cell-Free DNA in Fetal Aneuploidy Detection

cfDNA is a non-invasive method for detecting fetal aneuploidies during pregnancy cfDNA-based Noninvasive Prenatal Testing has an accuracy rate of over 99% for detecting trisomy 21 cfDNA can be ...
Nasdaq

Natera Launches Fetal Focus™: A Noninvasive Prenatal Test for Inherited Conditions

AUSTIN, Texas--(BUSINESS WIRE)-- Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA (cfDNA) testing and precision medicine, today announced the launch of Fetal Focus, a noninvasive prenatal ...
Medscape

Microarray-Based Prenatal Diagnosis for the Identification of Fetal Chromosome Abnormalities

JA Rosenfeld is an employee of Signature Genomic Laboratories, a subsidiary of PerkinElmer, Inc. The authors have no other relevant affiliations or financial involvement with any organization or ...
manilatimes

Myriad Genetics Unveils Groundbreaking Eight Weeks' Gestation NIPT Study Results at Society ...

SALT LAKE CITY, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced it will unveil groundbreaking research at ...